Coloplast A/s
(OTC) CLPBY
Coloplast A/s Financials at a Glance
Market Cap
$13.67B
Revenue (TTM)
$26.27B
Net Income (TTM)
$3.97B
EPS (TTM)
$0.27
P/E Ratio
24.53
Dividend
$0.36
Beta (Volatility)
0.58 (Low)
Dividend
$0.36
Beta (Volatility)
0.58 (Low)
Price
$6.59
Volume
1,489,307
Open
$6.70
Price
$6.59
Volume
1,489,307
Open
$6.70
Previous Close
$6.59
Daily Range
$6.54 - $6.71
52-Week Range
$6.54 - $11.44
Dividend
$0.36
Beta (Volatility)
0.58 (Low)
Price
$6.59
Volume
1,489,307
Open
$6.70
Previous Close
$6.59
Daily Range
$6.54 - $6.71
52-Week Range
$6.54 - $11.44
CLPBY News
CLPBY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Coloplast A/s
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
16,907
CEO
Lars Søren Rasmussen, MBA
Website
www.coloplast.comHeadquarters
Humlebæk, 3050, DK
CLPBY Financials
Key Financial Metrics (TTM)
Gross Margin
65%
Operating Margin
27%
Net Income Margin
14%
Return on Equity
28%
Return on Capital
18%
Return on Assets
8%
Earnings Yield
4.08%
Dividend Yield
0.05%
Payout Ratio
1.30%
Stock Overview
Market Cap
$13.67B
Shares Outstanding
2.07B
Volume
1.49M
Short Interest
0.00%
Avg. Volume
476.23K
Financials (TTM)
Gross Profit
$17.08B
Operating Income
$7.14B
EBITDA
$7.85B
Operating Cash Flow
$6.26B
Capital Expenditure
$1.23B
Free Cash Flow
$5.03B
Cash & ST Invst.
$948.88M
Total Debt
$22.68B
Coloplast A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.04B
+0.2%
Gross Profit
$4.69B
-1.2%
Gross Margin
66.63%
N/A
Market Cap
$13.67B
N/A
Market Cap/Employee
$816.29K
N/A
Employees
16,741
N/A
Net Income
$1.38B
+32.6%
EBITDA
$2.30B
-0.0%
Quarterly Fundamentals
Net Cash
$23.97B
-0.5%
Accounts Receivable
$4.84B
-2.5%
Inventory
$3.86B
+5.1%
Long Term Debt
$21.39B
+23.6%
Short Term Debt
$3.70B
-50.3%
Return on Assets
8.17%
N/A
Return on Invested Capital
18.39%
N/A
Free Cash Flow
$1.84B
+8.6%
Operating Cash Flow
$2.21B
+10.3%